Mutations associated with genotypic resistance to antiretroviral therapy in treatment naive HIV-1 infected patients in Greece

被引:15
作者
Magiorkinis, E
Paraskevis, D
Magiorkinis, G
Chryssou, S
Chini, M
Lazanas, M
Paparizos, V
Saroglou, G
Antoniadou, A
Giamarellou, E
Karafoulidou, A
Hatzakis, A
机构
[1] Univ Athens, Sch Med, Natl Retrovirus Ref Ctr, Dept Hyg & Epidemiol, GR-11527 Athens, Greece
[2] G Gennimatas Hosp, Athens, Greece
[3] Red Cross Hosp, Athens, Greece
[4] A Syngros Hosp, Athens, Greece
[5] Evangelismos Med Ctr, Athens, Greece
[6] Sismanogleion Hosp, Athens, Greece
[7] Laikon Gen Hosp, Hemophilia Ctr, Athens, Greece
关键词
naive; resistance; HIV-1; mutations;
D O I
10.1016/S0168-1702(02)00022-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The widespread use of antiviral drugs against HIV has increased the prevalence of HIV-1 resistant strains among naive individuals due to transmission of resistant strains. The purpose of this study was to investigate the presence of HIV-1 strains harboring resistance mutations in naive patients in Greece. Blood samples were collected from 25 individuals. The DNA sequence of protease and partial reverse transcriptase regions (codons 41-223) were obtained by direct sequencing. Our results showed the absence of any primary resistance mutations in the study population. However, we were able to identify high prevalence of sequence polymorphisms at positions in reverse transcriptase region associated mainly with resistance to NNRTIs. Moreover, in protease region several secondary mutations were detected, suggesting the higher genetic variability of this region. The clinical significance of the polymorphisms associated with reduced susceptibility to NNRTIs remains to be clarified. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 27 条
[1]   Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users [J].
Alexander, CS ;
Dong, W ;
Schechter, MT ;
O'Shaughnessy, MV ;
Strathdee, SA ;
Mo, T ;
Montaner, JSG ;
Harrigan, PR .
AIDS, 1999, 13 (08) :981-985
[2]  
[Anonymous], 1998, SIMPLOT WINDOWS VERS
[3]  
BALOTTA C, 1997, 12 WORLD AIDS C 1997
[4]   Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients [J].
Birk, M ;
Sönnerborg, A .
AIDS, 1998, 12 (18) :2369-2375
[5]   HIV-1 drug resistance in newly infected individuals [J].
Boden, D ;
Hurley, A ;
Zhang, LQ ;
Cao, YZ ;
Guo, Y ;
Jones, E ;
Tsay, J ;
Ip, J ;
Farthing, C ;
Limoli, K ;
Parkin, N ;
Markowitz, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12) :1135-1141
[6]   Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites [J].
Brown, AJL ;
Precious, HM ;
Whitcomb, JM ;
Wong, JK ;
Quigg, M ;
Huang, W ;
Daar, ES ;
D'Aquila, RT ;
Keiser, PH ;
Connick, E ;
Hellmann, NS ;
Petropoulos, CJ ;
Richman, DD ;
Little, SJ .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10269-10273
[7]  
CLOTET B, 2000, GUIDE MANAGEMENT HIV, P114
[8]   Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-l-positive German patients [J].
Dietrich, U ;
Raudonat, I ;
Wolf, E ;
Jäger, H ;
Husak, R ;
Orfanos, CE ;
Knickmann, M ;
Knechten, H ;
von Briesen, H ;
Ruppach, H ;
Immelmann, A .
AIDS, 1999, 13 (16) :2304-2305
[9]   BRIEF REPORT - PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ERICE, A ;
MAYERS, DL ;
STRIKE, DG ;
SANNERUD, KJ ;
MCCUTCHAN, FE ;
HENRY, K ;
BALFOUR, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) :1163-1165
[10]  
Felsenstein J., 1993, PHYLIP PHYLOGENY INF